Therapeutic target for periodontal disease.
申请人:Kao Corporation
公开号:EP2631648A3
公开(公告)日:2013-12-18
A marker for determining the onset of periodontal disease and a marker for determining the progression stage of periodontal disease, each containing autoinducer-2. A screening method for identifying improving agents or preventive agents for periodontal disease using autoinducer-2 as screening target has been disclosed. 4-bromo-5-(4-methoxyphenyl)-2(5H)-Furanone, 3,4-dibromo-5-hydroxy-2(5H)-Furanone, 4-bromo-5-methoxy-5-(4-methoxyphenyl)-2(5H)-Furanone and 4-[[3-bromo-2,5-dihydro-2-(4-methoxyphenyl)-5-oxo-2-furanyl]oxy]-Benzoic acid have been described as medicaments and are useful for treating periodontal disease.
一种用于确定牙周病发病阶段的标记物和一种用于确定牙周病进展阶段的标记物,均含有自身诱导体-2。此外,还公开了一种以自体诱导体-2 为筛选靶标的筛选方法,用于确定牙周病的改善剂或预防剂。4-bromo-5-(4-methoxyphenyl)-2(5H)-Furanone, 3,4-dibromo-5-hydroxy-2(5H)-Furanone, 4-bromo-5-methoxy-5-(4-methoxyphenyl)-2(5H)-Furanone and 4-[[3-bromo-2,5-二氢-2-(4-甲氧基苯基)-5-氧代-2-呋喃基]氧基]-苯甲酸已被描述为药物,可用于治疗牙周病。